1558

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Stock Price

SEHK:1558 Community·HK$14.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

1558 Share Price Performance

HK$15.88
1.76 (12.46%)
HK$15.88
1.76 (12.46%)
Price HK$15.88

1558 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and slightly overvalued.

1 Risk
1 Reward

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Key Details

CN¥3.7b

Revenue

CN¥929.7m

Cost of Revenue

CN¥2.8b

Gross Profit

CN¥2.3b

Other Expenses

CN¥482.7m

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
0.55
75.03%
12.96%
22.6%
View Full Analysis

About 1558

Founded
2001
Employees
4861
CEO
Wenjia Li
WebsiteView website
www.hec-changjiang.com

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. engages in the development, manufacturing, and sale of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic, and cardiovascular diseases in the People’s Republic of China. It manufactures and sells active pharmaceutical ingredients and drugs; researches and develops pharmaceutical products and medical devices, as well as biotechnology; and provides marketing and medical consulting services. The company’s product portfolio includes Kewei, Oumeining, Xinhaining, Ertongshu, and Xining. It sells its products to hospitals and medical institutions through a network of distributors. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China.

Recent 1558 News & Updates

Recent updates

No updates